Hey, That’s My Patent! Biotech Brouhaha Erupts Over Cloning Dogs

By Andrew Moseman | June 19, 2008 6:08 pm

black lab.
I’m not one of a kind?!?

There can be only one dog cloning operation, or so says Lou Hawthorne, the CEO of BioArts, a biotech company based in California.

You may have heard that a South Korean company called RNL Bio announced earlier this week that they produced four cloned copies of a Labrador retriever. The original dog, Marine, was excellent at cancer-sniffing—able to pick out breast, prostate, lung, and bladder cancer cells. But she couldn’t have puppies, so her owner, canine trainer Yuji Satoh, asked RNL Bio to clone her. Two of the four new Marines have been donated to Satoh’s training center and to the Seoul National University lab; the other two are on the market for a cool half-million dollars each. And RNL Bio announced plans to venture into the pet market, cloning your deceased canine if you’ve got the cash.

All these moves have ruffled Hawthorne’s feathers. In a perturbed press release today, he says that his company, BioArts, owns the sole worldwide rights to use it the dog-cloning procedure patented by Start Licensing, another American company. “RNL has no right to offer this service, and is practicing black market cloning,” Hawthorne says. “Individuals who wish to clone a beloved dog have only one legal option, and that’s our Best Friends Again program.”

This isn’t the first time Korean scientists have cloned dogs, and it’s not clear right now how the law will sort this out—Start Licensing has repeatedly threatened legal action, but according to the English-language South Korean newspaper JoongAng Daily, patent disputes are somewhat new to Korea. Seoul National University, the largest patent holders in South Korea, has some staff members connected to RNL Bio, but didn’t have a single patent attorney as of last month, according to the same article.

If courts or trade organizations don’t step in, the marketplace may decide this matter. Early next month, BioArts plans to hold a series of online auctions with six-figure opening prices where people can bid for the few available spots to have BioArts clone their pet. So dig out the checkbook, dog lovers—bidding starts July 5.

Image: flickr/MiikaS

  • robert2008

    Koreans are smart. They will change a few things and patent their own cloning process.
    That’s what the dumb American gets for trying to make a fast buck!

  • tkv001

    If patent rights can’t be upheld around the world then there would truly be chaos in the market. Companies invest millions of dollars in developing new technology. The only way they can often recoup that money is to have the protection that no one else will copy the technology they paid for. This is not a question of what ‘dump American’s get for trying to make a fast buck.’ BioArts paid a significant amount of money to license the patents. Why should a Korean company (or any other company for that matter) get to take advantage of expensive technology and patents without paying for it also? Can Americans or Europeans or Chinese or anyone else just start copying technology developed by Korean companies like LG, Samsung and Hyundai? Patent rights must be protected around the world. If Korea expects to be treated like a developed nation, then it must play by the developed nations’ intellectual property laws.

  • http://www.uspatentlaw.us Utah Patent Attorney

    The US Patent and Trademark Office is 1.5 million applications behind and counting. The supervisors at the USPTO work from home (!!!). Something needs to be done. Somebody please appoint somebody who will fix this problem.

  • Pingback: Biotech Company Selects World’s Worthiest Dog, and Wants to Clone it | Discoblog | Discover Magazine()

  • Pingback: Looking to Immortalize Your Pet? Now You Can Turn Muffy’s DNA Into a Diamond | Discoblog | Discover Magazine()

  • http://www.batemanip.com Utah Patent Lawyers

    I’m interested to hear the follow up. Also, it seems pretty far fetched to think that BioArts paid the funds to wrap up all the patentable countries.

    Ok. Bad pun, but it was fun.


Discover's Newsletter

Sign up to get the latest science news delivered weekly right to your inbox!


Quirky, funny, and surprising science news from the edge of the known universe.

See More

Collapse bottom bar